Despite the increased transduction efficiency of respiratory epithelial cells and the enhanced expression level of the CFTR gene in vivo in animal models using mucolytics, these agents have not been used in clinical trials for cystic fibrosis gene therapy. This evidence concerns the gene CFTR and cystic fibrosis.